Transparency Market Research
is Published new Market Report " Enteric Disease Testing Market
(Amebiasis, C.difficile Infection, Campylobacteriosis, Cholera,
Cryptosporidiosis, E.coli Infection, Giardiasis, H.pylori Infection, Norovirus
Infection, Rotavirus Infection, Salmonellosis and
Shigellosis) - Global Industry Analysis, Size, Share, Growth, Trends
and Forecast, 2013 - 2019," the global enteric disease
testing market was valued at USD 3.1 billion in 2012 and is expected to grow at
a CAGR of 2.4% from 2013 to 2019, to reach an estimated value of USD 3.6
billion in 2019.
Browse
the full report with complete TOC at http://www.transparencymarketresearch.com/enteric-disease-testing-market.html
Enteric diseases are major
causes of morbidity and mortality worldwide. Developing socio-economic
countries with poor drainage, sanitation along with overcrowding and low
hygiene awareness account for majority of enteric infection incidences
prevailing worldwide. These diseases usually exhibit mild symptoms but if not
treated on time can lead to severe complications, resulting in death. In order
to manage these diseases effectively, their early detection is essential.
Various enteric diseases responsible for diarrhea, stomach pain, nausea,
vomiting, anorexia, weight loss and fever are amebiasis, giardiasis,
rotavirus infection, salmonellosis and shigellosis.
Traditionally, diagnosis of
enteric infections relied on culture results of fecal specimen. Today, the
world is witnessing a paradigm shift from culture to EIA (enzyme immunoassaya)
and PCR (polymerase chain reaction) based tests owing to advantages associated
with these newer testing methods. EIA and PCR tests offer enhanced sensitivity
and specificity compared to culture tests and also give quick results. Globally
the market for enteric disease testing is growing at a CAGR of 2.4% under the
influence of rising awareness, demand for point of care testing and increasing
application of molecular diagnostics. Use of molecular diagnostic products has
made diagnosis easy and possible, even those strains which once seemed to be
difficult and impossible. North America and Europe represent the largest
regional markets because of rapid demand for molecular based diagnostics and
due to high level of awareness among people about the diseases. C.difficile
infection is one of the major causes of antibiotic related diarrhea in
developed regions.
Various epidemiological
sources including CDC and American Association for Clinical Chemistry suggest
that C.difficile infection incidence per 100,000 people has increased over the
past few decades in United States. In developing nations, frequent
travelling to regions where enteric diseases are epidemic is also one of the
reasons driving the market growth. Asia-Pacific and Africa have been predicted
to grow rapidly during the forecast period. In developing nations of
Asia-pacific, Africa and Latin America, the market is also growing
due to advent of rapid dipstick tests which can be applied by the patient
themself. These regions associated with inadequate healthcare infrastructure do
not possess substantial number of laboratories to perform laboratory based
tests.
Related
& Recently Published Reports by Transparency Market Research
- Industrial Controls and Robotics Market:http://www.transparencymarketresearch.com/industrial-robotics-market.html
- Glass Packaging Market: http://www.transparencymarketresearch.com/glass-packaging.html
- Latin America Adhesives and Sealants Market:http://www.transparencymarketresearch.com/latin-america-adhesives-sealants.html
Thus, rapid dipstick test
kits being inexpensive and easy to use are widely accepted in these regions for
managing enteric illness. Continuously improving economy and rising healthcare
expenditure in these regions are also anticipated to drive the market. The
market is also growing due to emergence of new strains; sources from
Eurosurveillance suggest that the norovirus infection is increasing worldwide,
including United Kingdom, the Netherlands, France, Japan and
Australia due to emergence of new strain of genotype II.4 (GII.4) that is also
known as Sydney strain.
Some of the major companies
leading the market for enteric disease testing are DiaSorin, Cepheid, Bio-Rad,
Trinity Biotech, Biomerica, Becton Dickinson, Meridian Bioscience, Alere and
bioMerieux.
The global enteric disease
testing market is segmented into the following categories:
Enteric Disease Testing Market, by types of
diseases
- Bacterial Enteric Disease Testing
- C.difficile Infection
- Campylobacteriosis
- Cholera
- E.coli Infection
- H.pylori Infection
- Salmonellosis
- Shigellosis
- Viral Enteric Disease Testing
- Rotavirus Infection
- Norovirus Infection
- Parasitic Enteric Disease Testing
- Amebiasis
- Cryptosporidiosis
- Giardiasis
Enteric Disease Testing Market, by
Geography
- North America
- Europe
- Asia-Pacific
- Africa
- Latin America
- Rest of the World (RoW)
Blogs
:
No comments:
Post a Comment